San Francisco, CA, United States of America

Brooke Blair


 

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 52(Granted Patents)


Location History:

  • San Francisco, CA (US) (2011 - 2013)
  • Williamstown, MA (US) (2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Brooke Blair: Innovator in Antihypertensive Agents

Introduction

Brooke Blair is a prominent inventor based in San Francisco, CA, known for her significant contributions to the field of pharmaceuticals. With a total of eight patents to her name, she has made remarkable strides in developing dual-acting antihypertensive agents. Her work focuses on innovative compounds that offer new therapeutic options for managing hypertension.

Latest Patents

Among her latest patents, Brooke has developed dual-acting antihypertensive agents. One aspect of this invention relates to compounds characterized by specific formulas, which include AT receptor antagonist activity and neprilysin inhibition activity. These compounds are designed to improve the efficacy of hypertension treatment. Additionally, she has patented dual-acting pyrazole antihypertensive agents, which also feature similar properties and applications in pharmaceutical compositions.

Career Highlights

Brooke has worked with notable companies such as Theravance, Inc. and Theravance Biopharma R&D IP, LLC. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects, further enhancing her expertise in the pharmaceutical industry.

Collaborations

Throughout her career, Brooke has collaborated with esteemed colleagues, including Paul Ross Fatheree and Roland Gendron. These partnerships have contributed to her innovative work and the successful development of her patented compounds.

Conclusion

Brooke Blair's contributions to the field of antihypertensive agents exemplify her dedication to innovation in pharmaceuticals. Her patents reflect her commitment to improving healthcare outcomes for patients with hypertension.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…